Balchem projects strong 2025 growth amid new product launches and robust segment performance
Q4 2024 Management View According to Ted Harris, Chairman, President, and CEO, Balchem achieved record consolidated sales of $240 million in Q4 2024, representing 4.9% growth year-over-year. Adjusted ...
manilatimes14h
Teva and Alvotech Announce SELARSDI™ (ustekinumab-aekn) Injection Now Available in the U.S.
In October 2024, the U.S. Food and Drug Administration (FDA) approved SELARSDI™ for all indications matching the reference ...
Sturm Ruger projects $20M in 2025 capital expenditures with strong new product pipeline
Q4 2024 Management View CEO Chris Killoy highlighted the significant impact of the new RXM 9-millimeter pistol, developed in collaboration with Magpul Industries. He described it as “the most ...